Tag: Pharmaceutical Industry Regulations
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount ProgramA recent warning from a U.S. government agency has put pharmaceutical giant Sanofi in hot water over its decision to alter payment terms...
Debate over GLP-1 Drugs in Trump Administration: What You Need to Know
Debate Over GLP-1 Drugs in Trump Administration: What You Need to KnowIn a whirlwind of developments in the biotech world, major restructuring at Editas Medicine, a new commercialization strategy from Ionis Pharmaceuticals, and differing...
Mitigating Drug Shortages: Insights from a New Study on Canada
A recent study compared the likelihood of drug shortages in Canada and the United States and found that Canada was 40% less likely to experience meaningful shortages. The study analyzed 104 reports of supply...
FDA Urged to Withdraw Approval of Over 400 Tainted Medicines
The FDA recently discovered that a testing facility in India submitted fraudulent data for over 400 drugs, most of which are generics. Despite this, the agency has allowed these drugs to remain on the...
BREAKING NEWS
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee...
